According to data from a phase 2 trial, the new treatment Tovorafenib resulted in significant tumour shrinkage in 64% of patients with low-grade gliomas in children, a clinical benefit rate of 91%.
"Men"
-
-
Brigham and Women's Hospital (formerly Brigham and Women's Hospital), also known as Brigham and Women's Hospital, has a long history and is the second largest hospital affiliated with Harvard Medical School in the United States. Hospital (founded in 1832), which merged in 1980
-
Medical
Japanese Scientists Find That Nmn Supplementation May Treat Retinal Dysfunction Caused By Cardiovascular Disease
New research by japanese scientists has found that
-
Disease
Don't Wait Until You'Re 50 To Start Preventing Osteoporosis! Reminder: These 5 Calcium Supplements Are Reliable
Osteoporosis is the cause of menopausal fractures! Do these 5 things to avoid osteoporosis
-
Leukaemia is a very complex disease that causes fever and infection and bleeding, so it needs to be treated early so that it can be gradually controlled and the patient's symptoms can be gradually relieved
-
An obvious feature of autumn that is different from summer is that the temperature drops, the weather is unpredictable, and the temperature difference between morning and night is large, which has become one of the main causes of female biological clock disorder, endocrine disorder and bacterial infection in autumn. In addition, the resistance of the human body decreases relatively in autumn, which is also a time of high recurrence for patients with gynecological diseases.
-
Apparatus
Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd
Approval for new FIC depression drug on the horizon!
-
Disease
For Both Men And Women, These 6 Signs On The Legs Indicate That There Is Blood Clot In The Body, Do Not Delay
This is the best way to prevent blood clots.
-
According to researchers at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, a new treatment that helps the immune system kill multiple myeloma cancer cells has benefited up to 73% of patients in 2 clinical trials!
-
The trial is testing the effectiveness of two chemotherapy drugs, oxaliplatin and gemcitabine, in combination with radiotherapy, an approach that has been used to treat other aggressive tumours